Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
Again, my previous article included more industry overview, but I thought I would add a little more here. I am writing this article comparing my tier two companies for a couple of reasons. First, this ...
Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4fj74t/pharmaceutical) has announced the addition of the "Pharmaceutical ...
Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Among the demands that ...
AI has infiltrated seemingly every facet of business over the last year. The pharmaceutical industry is no different, and this technology’s rapid evolution can change drug development forever. However ...
New York, May 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical & Healthcare Annual Deals Analysis: M&A and ...
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/81c5d0/china_pharmaceutic) has announced the addition of the "China ...
High-performance liquid chromatography-mass spectrometry (HPLC-MS) combines the separation power of LC with the detection specificity of MS. It has become an indispensable analytical tool in the ...
Elemental analysis plays a crucial role in the pharmaceutical industry, allowing scientists to understand a material or compound’s elemental composition. It also provides key information on any ...
Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but is still on course for a major defeat by failing to stop a bill that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results